Logo
Login
$QDEL
$13.77 +$0.04 (0.29%) Close

Company Executives

$QDEL Management Team

Dr. Kenneth Buechler

Independent Chairman of the Board

Age 67
Compensation $309.8K USD
Sex Male

Mr. Douglas Bryant

President

Chief Executive Officer

Director

Age 63
Compensation $7.178M USD
Sex Male

Mr. Randall Steward

Chief Financial Officer

Age 66
Compensation $2.514M USD
Sex Male

Mr. Robert Bujarski

Chief Operating Officer

Age 52
Compensation $2.244M USD
Sex Male

Ms. Michelle Hodges

Senior Vice President

General Counsel

Age 61
Compensation -
Sex Female

Mr. William Ferenczy

Senior Vice President - Cardiometabolic Business Unit

Age 65
Compensation -
Sex Male

Ms. Karen Gibson

Senior Vice President - Digital Health Business Unit

Age 59
Compensation -
Sex Female

Dr. Werner Kroll

Senior Vice President - R&D

Age 64
Compensation $2.510M USD
Sex Male

Dr. Tamara Ranalli

Senior Vice President - Molecular Business

Age 48
Compensation -
Sex Female

Mr. Edward Russell

Senior Vice President - Business Development

Age 53
Compensation $1.112M USD
Sex Male

Board of Directors

From the proxy statement filed Apr 27, 2026
Directors
11
serving now
Independent
10 of 11
stated in the proxy
Average tenure
9.3 years
from year joined
CEO also chairs the board
No
Kenneth F. Buechler, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Brian J. Blaser
CEO
 61 2024
2 years
 Not independent None stated None stated Paid as CEO
Kenneth F. Buechler, Ph.D.
Board chair
 72 2007
19 years
 Independent
Nominating and Governance Committee Science and Technology Committee · Chair
None stated $424,477
John R. Chiminski
62 2024
2 years
 Independent
Audit Committee Science and Technology Committee
None stated $316,076
Evelyn S. Dilsaver
70 2022
4 years
 Independent
Audit Committee
Tempur Sealy International Inc. $285,000
R. Scott Huennekens
61 2024
2 years
 Independent None stated Envista Holdings Corporation, NeuroPace Inc. $301,101
Edward L. Michael
69 2018
8 years
 Independent
Compensation Committee · Chair Science and Technology Committee
None stated $323,973
Mary Lake Polan, M.D., Ph.D., M.P.H.
82 1993
33 years
 Independent
Compensation Committee Science and Technology Committee
None stated $307,478
Ann D. Rhoads
60 2020
6 years
 Independent
Audit Committee · Chair
Globus Medical Inc. $319,994
Kenneth J. Widder, M.D.
73 2014
12 years
 Independent
Nominating and Governance Committee · Chair Science and Technology Committee
Personalis, Inc. $326,999
Joseph D. Wilkins Jr.
64 2021
5 years
 Independent
Compensation Committee Nominating and Governance Committee
None stated $285,000
Matthew W. Strobeck Leaving at the meeting
Not stated Not stated Independent
Audit Committee Science and Technology Committee
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 27, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans